Trends and Forecast Evaluation of the Peptic Ulcer Drugs Market by 2024–2034
The Peptic Ulcer Drugs Market is projected to grow steadily from 2024 to 2034, driven by the rising prevalence of peptic ulcer disease (PUD), aging populations, increased use of NSAIDs, Helicobacter pylori infections, and growing awareness of gastrointestinal health. Peptic ulcer drugs—including proton pump inhibitors (PPIs), H2 receptor antagonists (H2RAs), antibiotics for H. pylori...
0 Commentarios 0 Acciones 144 Views 0 Vista previa
Patrocinados